Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NOT IN KANSAS

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston May 25, 2022 11:18am

230 Views

Post# 34706390

RE:RE:RE:NOT IN KANSAS

Legit62 ... 10$US/share would give TLT a market valuation of 2B$US for 204M share (TSO), which is in the valuation bracket of oncology drugs that are seen as growing candidates whether for a takeover or ones that are seen as jv candidates.

In our case, given that we instantly destroy without any assistance, with no toxicity, with only 2 treatments, we could be valued a bit higher just for the NMIBC indication alone, if our data points to a future SOC (standard of care) treatment.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale